Protective Impact of Influenza Vaccination on Healthcare Workers.

IF 5.2 3区 医学 Q1 IMMUNOLOGY Vaccines Pub Date : 2024-10-30 DOI:10.3390/vaccines12111237
Yimei Tian, Yue Ma, Jianchao Ran, Lifang Yuan, Xianhu Zeng, Lu Tan, Li Chen, Yifan Xu, Shaxi Li, Ting Huang, Hongzhou Lu
{"title":"Protective Impact of Influenza Vaccination on Healthcare Workers.","authors":"Yimei Tian, Yue Ma, Jianchao Ran, Lifang Yuan, Xianhu Zeng, Lu Tan, Li Chen, Yifan Xu, Shaxi Li, Ting Huang, Hongzhou Lu","doi":"10.3390/vaccines12111237","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Influenza vaccine uptake among healthcare workers is crucial for preventing influenza infections, yet its effectiveness needs further investigation.</p><p><strong>Objectives: </strong>This prospective observational study aimed to assess the protective effect of influenza vaccination among healthcare workers in Shenzhen.</p><p><strong>Methods: </strong>We enrolled 100 participants, with 50 receiving the 2023-2024 quadrivalent influenza vaccine (QIV) and 50 serving as unvaccinated controls. Epidemiological data were collected when the participants presented influenza-like illness. Serum samples were collected at three time points (pre-vaccination and 28 and 180 days after vaccination). Hemagglutination inhibition (HI) assay was performed against the strains included in the 2023-2024 QIV (H1N1, H3N2, BV and BY strains) to assess antibody protection levels. Demographics comparisons revealed no significant differences between the vaccinated and control groups (<i>p</i> > 0.05), ensuring group comparability.</p><p><strong>Results: </strong>The incidence of influenza-like illness was significantly lower in the vaccinated (18%) compared to the control group (36%; <i>p</i> = 0.046; OR = 0.39; 95% CI: 0.15 to 0.98). The vaccinated group also exhibited a higher rate of consecutive two-year vaccinations (48% vs. 24% in the control group, <i>p</i> < 0.05). Additionally, the vaccinated healthcare workers were more inclined to recommend vaccination to their families (80% vs. 48%, <i>p</i> < 0.05). HI titers against H1N1 (<i>p</i> < 0.01), H3N2 (<i>p</i> < 0.01), BV (<i>p</i> < 0.001) and BY (<i>p</i> < 0.01) significantly increased in the vaccinated group at 28 days post-vaccination. Moreover, a marked and sustained increase in HI titers against the H3N2 strain (<i>p</i> < 0.001) was observed at 180 days post-vaccination, highlighting the vaccine's enduring impact on the immune response. The fold change in the HI titers, indicative of the magnitude of the immune response, was significantly higher for H1N1 (<i>p</i> < 0.01), H3N2 (<i>p</i> < 0.001), BV (<i>p</i> < 0.01) and BY (<i>p</i> < 0.05) among the vaccinated individuals compared to the control group, underscoring the vaccine's efficacy in eliciting a robust and sustained antibody response.</p><p><strong>Conclusion: </strong>Influenza vaccination significantly reduces the incidence of influenza-like illness among healthcare workers and promotes a sustained immune response. The study supports the importance of annual vaccination for this group to enhance personal and public health.</p>","PeriodicalId":23634,"journal":{"name":"Vaccines","volume":"12 11","pages":""},"PeriodicalIF":5.2000,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11599008/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vaccines","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/vaccines12111237","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Influenza vaccine uptake among healthcare workers is crucial for preventing influenza infections, yet its effectiveness needs further investigation.

Objectives: This prospective observational study aimed to assess the protective effect of influenza vaccination among healthcare workers in Shenzhen.

Methods: We enrolled 100 participants, with 50 receiving the 2023-2024 quadrivalent influenza vaccine (QIV) and 50 serving as unvaccinated controls. Epidemiological data were collected when the participants presented influenza-like illness. Serum samples were collected at three time points (pre-vaccination and 28 and 180 days after vaccination). Hemagglutination inhibition (HI) assay was performed against the strains included in the 2023-2024 QIV (H1N1, H3N2, BV and BY strains) to assess antibody protection levels. Demographics comparisons revealed no significant differences between the vaccinated and control groups (p > 0.05), ensuring group comparability.

Results: The incidence of influenza-like illness was significantly lower in the vaccinated (18%) compared to the control group (36%; p = 0.046; OR = 0.39; 95% CI: 0.15 to 0.98). The vaccinated group also exhibited a higher rate of consecutive two-year vaccinations (48% vs. 24% in the control group, p < 0.05). Additionally, the vaccinated healthcare workers were more inclined to recommend vaccination to their families (80% vs. 48%, p < 0.05). HI titers against H1N1 (p < 0.01), H3N2 (p < 0.01), BV (p < 0.001) and BY (p < 0.01) significantly increased in the vaccinated group at 28 days post-vaccination. Moreover, a marked and sustained increase in HI titers against the H3N2 strain (p < 0.001) was observed at 180 days post-vaccination, highlighting the vaccine's enduring impact on the immune response. The fold change in the HI titers, indicative of the magnitude of the immune response, was significantly higher for H1N1 (p < 0.01), H3N2 (p < 0.001), BV (p < 0.01) and BY (p < 0.05) among the vaccinated individuals compared to the control group, underscoring the vaccine's efficacy in eliciting a robust and sustained antibody response.

Conclusion: Influenza vaccination significantly reduces the incidence of influenza-like illness among healthcare workers and promotes a sustained immune response. The study supports the importance of annual vaccination for this group to enhance personal and public health.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
流感疫苗对医护人员的保护作用。
背景:医护人员接种流感疫苗对预防流感感染至关重要,但其有效性还需进一步研究:本前瞻性观察研究旨在评估深圳医护人员接种流感疫苗的保护效果:我们招募了 100 名参与者,其中 50 人接种了 2023-2024 年四价流感疫苗(QIV),50 人作为未接种对照。在参与者出现流感样病症时收集流行病学数据。在三个时间点(接种前、接种后 28 天和 180 天)收集血清样本。针对 2023-2024 年 QIV 所含毒株(H1N1、H3N2、BV 和 BY 毒株)进行了血凝抑制(HI)检测,以评估抗体保护水平。人口统计学比较显示,接种组和对照组之间没有显著差异(P > 0.05),确保了组间的可比性:结果:与对照组(36%;P = 0.046;OR = 0.39;95% CI:0.15 至 0.98)相比,接种组的流感样疾病发病率(18%)明显降低。接种组连续两年接种疫苗的比例也更高(48% 对对照组的 24%,p < 0.05)。此外,接种疫苗的医护人员更愿意向家人推荐接种疫苗(80% 对 48%,P < 0.05)。接种疫苗后 28 天,接种组对 H1N1(p < 0.01)、H3N2(p < 0.01)、BV(p < 0.001)和 BY(p < 0.01)的 HI 滴度显著上升。此外,在接种后 180 天,观察到针对 H3N2 株的高致病性禽流感滴度(p < 0.001)有明显和持续的增加,这凸显了疫苗对免疫反应的持久影响。与对照组相比,接种疫苗者对 H1N1(p < 0.01)、H3N2(p < 0.001)、BV(p < 0.01)和 BY(p < 0.05)株的 HI 滴度的折叠变化(表明免疫反应的程度)明显较高,这突出表明了疫苗在激发强大而持久的抗体反应方面的功效:结论:接种流感疫苗可大大降低医护人员流感样疾病的发病率,并促进持续的免疫反应。这项研究证明了每年为这一群体接种疫苗对增进个人和公众健康的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Vaccines
Vaccines Pharmacology, Toxicology and Pharmaceutics-Pharmacology
CiteScore
8.90
自引率
16.70%
发文量
1853
审稿时长
18.06 days
期刊介绍: Vaccines (ISSN 2076-393X) is an international, peer-reviewed open access journal focused on laboratory and clinical vaccine research, utilization and immunization. Vaccines publishes high quality reviews, regular research papers, communications and case reports.
期刊最新文献
Preliminary Study on Type I Interferon as a Mucosal Adjuvant for Human Respiratory Syncytial Virus F Protein. Association Between Influenza Vaccine and Immune Thrombocytopenia: A Systematic Review and Meta-Analysis. Childhood Mandatory Vaccinations: Current Situation in European Countries and Changes Occurred from 2014 to 2024. Human Papillomavirus (HPV) Vaccination: Progress, Challenges, and Future Directions in Global Immunization Strategies. Sindbis Virus Replicon-Based SARS-CoV-2 and Dengue Combined Vaccine Candidates Elicit Immune Responses and Provide Protective Immunity in Mice.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1